This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Dexcom sees Munich local UPC court revoke its glucose monitor patent

( July 31, 2024, 10:41 GMT | Official Statement) -- MLex Summary: Dexcom today saw one of its patents pertaining to continuous glucose monitors revoked today in a decision by the Unified Patent Court's local Munich division. Earlier this month, the Paris court had already revoked a parent patent — EP 3,435,866 — for the same technology. The patent revoked today specifically concerns communication protocols (Bluetooth/BLE and NFC/RFID) for continuous glucose monitoring.Court decision attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login